Brief: Johnson & Johnson To Acquire Shockwave Medical

Shockwave Medical

05/04/2024 12:13

April 5 (Reuters) - Johnson & Johnson  JNJ.N :
    * JOHNSON & JOHNSON TO ACQUIRE SHOCKWAVE MEDICAL
    * J&J: PROPOSED DEAL FOR $335.00 PER SHARE IN CASH,
    * J&J - PROPOSED DEAL FOR $13.1 BILLION
    * J&J - PROPOSED DEAL FOR ENTERPRISE VALUE OF APPROXIMATELY
$13.1
BILLION INCLUDING CASH ACQUIRED
    * J&J: PROPOSED DEAL FOR ENTERPRISE VALUE OF APPROXIMATELY
$13.1
BILLION INCLUDING CASH ACQUIRED
    * J&J - TRANSACTION WILL BE ACCRETIVE TO OPERATING MARGIN
FOR BOTH
JOHNSON & JOHNSON AND JOHNSON & JOHNSON MEDTECH
    * J&J: EXPECTS TO FUND TRANSACTION THROUGH A COMBINATION OF
CASH
ON HAND AND DEBT
    * J&J - CLOSING OF TRANSACTION IS EXPECTED TO OCCUR BY
MID-YEAR
2024
    * J&J: DEAL EXPECTED TO DILUTE ADJUSTED EARNINGS PER SHARE
BY
ABOUT $0.10 IN 2024 AND APPROXIMATELY $0.17 IN 2025
    * J&J: SHOCKWAVE WILL OPERATE AS A BUSINESS UNIT WITHIN
JOHNSON &
JOHNSON MEDTECH
    * J&J: MICHAEL BODNER WILL ASSUME RESPONSIBILITY FOR
SHOCKWAVE
UPON CLOSE
    * J&J -  ISAAC ZACHARIAS WILL TRANSITION TO BECOME WORLDWIDE
PRESIDENT OF SHOCKWAVE, REPORTING TO MICHAEL BODNER
    * J&J: DOUG GODSHALL, SHOCKWAVE'S PRESIDENT AND CHIEF
EXECUTIVE
OFFICER, WILL ADVISE THROUGH TRANSITION
    * J&J - FOLLOWING COMPLETION OF TRANSACTION, SHOCKWAVE'S
COMMON
STOCK WILL NO LONGER BE LISTED FOR TRADING ON NASDAQ GLOBAL
SELECT MARKET

Source text for Eikon:  ID:nBw9ZV0R9a 
Further company coverage:  JNJ.N